SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the t:slim®, t:flex® and t:slim G4™
Insulin Pumps, today announced that Kim Blickenstaff, president and CEO,
will present a company update at the Cowen and Company 36th
Annual Health Care Conference in Boston, MA. The presentation will take
place on Wednesday, March 9, 2016 at 8:00am Eastern Time (5:00am Pacific
The presentation will be webcast live, and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com
in the "Investor Events" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company with an innovative, user-centric and
integrated approach to the design, development and commercialization of
products for people with diabetes who use insulin. The Company
manufactures and sells a family of insulin pump products, which includes
the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump
currently on the market, the t:flex® Insulin Pump, the first pump
designed for people with greater insulin requirements, and the t:slim
G4™ Insulin Pump, the first CGM-enabled pump with touch-screen
simplicity. Tandem is based in San Diego, California.
t:slim, t:flex and Tandem Diabetes Care are registered trademarks, and
t:slim G4 is a trademark of Tandem Diabetes Care, Inc.
Follow Tandem Diabetes Care:
Twitter @tandemdiabetes, use #tslim,
#tflex, #tslimG4, #tconnect and $TNDM.
Facebook at www.facebook.com/TandemDiabetes
View source version on businesswire.com: http://www.businesswire.com/news/home/20160223006491/en/
Tandem Diabetes Care, Inc.
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media